Primary Care/Hospitalist
RSSArticles
-
Aspergillus niger-derived Prolyl Endoprotease Improves Gluten Degradation
A prolyl endoprotease derived from Aspergillus niger has been shown to be capable of degrading gluten at the level of the stomach from both low- and high-calorie meals, minimizing duodenal and small intestine exposure to gluten. The use the prolyl endoprotease enzyme lowered α-gliadin concentration in the stomach and duodenum and absolute α-gliadin exposure in the duodenum over 240 minutes after consumption of a gluten-containing meal.
-
The Safety of Yoga
These authors performed a systematic review of the literature to ascertain the safety of yoga and found that yoga is not associated with an increased frequency of nonserious or serious adverse events compared with usual care or exercise.
-
Ten Weeks of Yoga Improves Symptomatology in Women with PTSD
A 10-week “trauma-informed” yoga practice, more than health education classes, aided women with chronic, treatment-resistant PTSD.
-
Electroacupuncture for Hot Flashes Among Breast Cancer Survivors
Electroacupuncture produces a greater placebo effect than oral medication when attempting to treat hot flashes in breast cancer survivors.
-
Clinical Briefs
In this section: improving cardiovascular outcomes through early treatment of diabetes; re-thinking PTSD treatment in veterans; and a link between rosacea and cardiovascular disease.
-
Flibanserin Tablets (Addyi)
The FDA has approved the first drug for the treatment of hypoactive sexual desire disorder in women.
-
The Impact of Hypoglycemia on Renal Impairment
A retrospective cohort study evaluated renal function data of 101 patients with type 2 diabetes and a history of severe hypoglycemia compared with a matched group of individuals with type 2 diabetes with no history of hypoglycemia.
-
Efficacy and Safety of Very Early Mobilization After Onset of Acute Stroke
The higher dose, very early (within 24 hours) mobilization protocol was associated with a reduction in the odds of a favorable outcome at 3 months after stroke occurrence.
-
SPRINT: The Systolic Blood Pressure Trial or ‘How Low Do You Go?’
Designed to see if lower blood pressures reduced the risk of blood pressure-related health outcomes, the NIH ended the SPRINT trial early and issued a news release that a lower blood pressure target significantly reduces cardiovascular complications in adults age 50 and older with high blood pressure.
-
Valve Disease and Thromboembolic Risk
The CHA2DS2-VASc score for the prediction of stroke and other thromboembolism risk in patients with atrial fibrillation has been validated in patients with non-valvular atrial fibrillation.